Format

Send to

Choose Destination
Nat Med. 2018 Sep;24(9):1301-1302. doi: 10.1038/s41591-018-0180-x.

Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge.

Author information

1
Office of Cancer Clinical Proteomics Research, Center for Strategic Scientific Initiatives, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. emily.boja@nih.gov.
2
Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA. zivana.tezak@fda.hhs.gov.
3
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
4
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
5
Office of Health Informatics, Office of the Chief Scientist, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD, USA.
6
Office of the Chief Scientist, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD, USA.
7
Office of Cancer Clinical Proteomics Research, Center for Strategic Scientific Initiatives, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
PMID:
30194412
DOI:
10.1038/s41591-018-0180-x

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center